Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 18 studies | 40% ± 19% | |
| endothelial cell | 8 studies | 33% ± 18% | |
| plasma cell | 7 studies | 26% ± 12% | |
| B cell | 7 studies | 25% ± 6% | |
| macrophage | 6 studies | 24% ± 5% | |
| epithelial cell | 6 studies | 24% ± 7% | |
| basal cell | 6 studies | 27% ± 7% | |
| retinal rod cell | 5 studies | 27% ± 7% | |
| memory B cell | 5 studies | 22% ± 5% | |
| naive B cell | 5 studies | 20% ± 4% | |
| pericyte | 4 studies | 30% ± 13% | |
| type I pneumocyte | 4 studies | 25% ± 8% | |
| retinal cone cell | 4 studies | 30% ± 11% | |
| CD4-positive, alpha-beta T cell | 4 studies | 21% ± 2% | |
| conventional dendritic cell | 4 studies | 22% ± 2% | |
| mast cell | 4 studies | 19% ± 2% | |
| deuterosomal cell | 3 studies | 25% ± 1% | |
| capillary endothelial cell | 3 studies | 24% ± 3% | |
| Mueller cell | 3 studies | 41% ± 8% | |
| enteroendocrine cell | 3 studies | 16% ± 1% | |
| goblet cell | 3 studies | 19% ± 2% | |
| gamma-delta T cell | 3 studies | 21% ± 5% | |
| CD8-positive, alpha-beta T cell | 3 studies | 22% ± 3% | |
| natural killer cell | 3 studies | 25% ± 7% | |
| regulatory T cell | 3 studies | 19% ± 3% | |
| mature NK T cell | 3 studies | 20% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 430.43 | 245 / 245 | 100% | 23.63 | 502 / 502 |
| brain | 98% | 354.28 | 2599 / 2642 | 97% | 5.76 | 685 / 705 |
| kidney | 99% | 344.00 | 88 / 89 | 95% | 9.27 | 859 / 901 |
| bladder | 100% | 321.71 | 21 / 21 | 90% | 6.38 | 454 / 504 |
| pancreas | 94% | 197.24 | 309 / 328 | 96% | 7.03 | 170 / 178 |
| uterus | 94% | 285.97 | 160 / 170 | 95% | 9.27 | 435 / 459 |
| ovary | 100% | 808.34 | 180 / 180 | 89% | 4.58 | 382 / 430 |
| skin | 93% | 336.37 | 1690 / 1809 | 95% | 8.09 | 448 / 472 |
| breast | 99% | 357.97 | 456 / 459 | 89% | 4.38 | 990 / 1118 |
| thymus | 97% | 282.28 | 633 / 653 | 90% | 4.96 | 546 / 605 |
| lung | 96% | 311.10 | 552 / 578 | 88% | 5.90 | 1020 / 1155 |
| esophagus | 98% | 568.04 | 1422 / 1445 | 80% | 3.90 | 147 / 183 |
| intestine | 94% | 265.41 | 912 / 966 | 83% | 5.46 | 437 / 527 |
| adrenal gland | 63% | 149.68 | 163 / 258 | 93% | 7.72 | 213 / 230 |
| stomach | 86% | 208.43 | 307 / 359 | 69% | 3.63 | 198 / 286 |
| liver | 75% | 270.31 | 169 / 226 | 54% | 3.21 | 218 / 406 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.45 | 1 / 1 |
| blood vessel | 100% | 1395.51 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 99% | 441.42 | 1192 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 99% | 432.97 | 794 / 803 | 0% | 0 | 0 / 0 |
| spleen | 98% | 241.94 | 236 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 9.70 | 44 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 6.39 | 28 / 29 |
| heart | 95% | 411.26 | 818 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 79% | 3.19 | 63 / 80 |
| peripheral blood | 62% | 569.84 | 574 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0001673 | Cellular component | male germ cell nucleus |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0005515 | Molecular function | protein binding |
| Gene name | ANKRD37 |
| Protein name | Ankyrin repeat domain-containing protein 37 (Low-density lipoprotein receptor-related protein 2-binding protein) (hLrp2bp) Ankyrin repeat domain 37 |
| Synonyms | LPR2BP |
| Description | |
| Accessions | ENST00000507753.1 ENST00000335174.6 D6RFF5 Q7Z713 |